Literature DB >> 30332666

Defining the Molecular Genetics of Dermoscopic Naevus Patterns.

Jean-Marie Tan1, Lisa N Tom1, H Peter Soyer1,2, Mitchell S Stark3.   

Abstract

Melanocytic naevi are common melanocytic proliferations that may simulate the appearance of cutaneous melanoma. Naevi commonly harbour somatic mutations implicated in melanomagenesis but in most cases lack the necessary genomic alterations required for melanoma development. While the mitogen-activated protein kinase pathway and ultraviolet radiation strongly contribute to naevogenesis, the somatic mutational landscape of dermoscopic naevus subsets distinguishes some of the molecular hallmarks of naevi in relation to melanoma. We herein discuss the classification of naevi and theories of naevogenesis and review the current literature on the somatic alterations in naevi and melanoma. This review focusses on the clinical-dermoscopic-pathological and genomic correlation of naevi that shapes the current understanding of naevi.
© 2018 S. Karger AG, Basel.

Entities:  

Keywords:  BRAF; Copy number; Dermoscopy; Globular naevus; Mutation; NRAS; Naevi; Peripheral rim of globules; Reticular naevus; Signature

Mesh:

Year:  2018        PMID: 30332666     DOI: 10.1159/000493892

Source DB:  PubMed          Journal:  Dermatology        ISSN: 1018-8665            Impact factor:   5.366


  2 in total

Review 1.  Dermoscopic Criteria, Histopathological Correlates and Genetic Findings of Thin Melanoma on Non-Volar Skin.

Authors:  Cesare Massone; Rainer Hofman-Wellenhof; Stefano Chiodi; Simona Sola
Journal:  Genes (Basel)       Date:  2021-08-23       Impact factor: 4.096

2.  Genome-Scale DNA Methylation Analysis Identifies Repeat Element Alterations that Modulate the Genomic Stability of Melanocytic Nevi.

Authors:  Meghan E Muse; Drew T Bergman; Lucas A Salas; Lisa N Tom; Jean-Marie Tan; Antonia Laino; Duncan Lambie; Richard A Sturm; Helmut Schaider; H Peter Soyer; Brock C Christensen; Mitchell S Stark
Journal:  J Invest Dermatol       Date:  2021-12-03       Impact factor: 7.590

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.